HomeCOGT • NASDAQ
add
Cogent Biosciences Inc
Previous close
$9.19
Day range
$9.07 - $9.35
Year range
$3.67 - $12.61
Market cap
1.02B USD
Avg Volume
1.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 75.41M | 26.58% |
Net income | -70.63M | -27.54% |
Net profit margin | — | — |
Earnings per share | -0.64 | 0.00% |
EBITDA | -74.79M | -26.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 335.52M | 20.24% |
Total assets | 384.02M | 8.04% |
Total liabilities | 69.36M | 31.99% |
Total equity | 314.66M | — |
Shares outstanding | 110.46M | — |
Price to book | 4.97 | — |
Return on assets | -46.33% | — |
Return on capital | -52.09% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -70.63M | -27.54% |
Cash from operations | -51.98M | -36.90% |
Cash from investing | 60.19M | 166.48% |
Cash from financing | 624.00K | -37.60% |
Net change in cash | 8.83M | 106.92% |
Free cash flow | -22.21M | -7.08% |
About
Founded
2014
Headquarters
Website
Employees
164
